Abstract

Background Clostridioides difficile is a major cause of healthcare-associated and community-acquired diarrhea. Host genetic susceptibility to Clostridioides difficile infection has not been studied on a large-scale.MethodsA total of 1,160 Clostridioides difficile infection cases and 15,304 controls were identified by applying the eMERGE Clostridioides difficile infection algorithm to electronic health record data. A genome-wide association study was performed using a linear mixed model, adjusted for significant covariates in the full dataset and the antibiotic subgroup. Colocalization and MetaXcan were performed to identify potential target genes in Clostridioides difficile infection - relevant tissue types.ResultsNo significant genome-wide association was found in the meta-analyses of the full Clostridioides difficile infection dataset. One genome-wide significant variant, rs114751021, was identified (OR = 2.42; 95%CI = 1.84-3.11; p=4.50 x 10-8) at the major histocompatibility complex region associated with Clostridioides difficile infection in the antibiotic group. Colocalization and MetaXcan identified MICA, C4A/C4B, and NOTCH4 as potential target genes. Down-regulation of MICA, upregulation of C4A and NOTCH4 was associated with a higher risk for Clostridioides difficile infection.ConclusionsLeveraging the EHR and genetic data, genome-wide association, and fine-mapping techniques, this study identified variants and genes associated with Clostridioides difficile infection, provided insights into host immune mechanisms, and described the potential for novel treatment strategies for Clostridioides difficile infection. Future replication and functional validation are needed.

Highlights

  • Clostridioides difficile (C. difficile) is an anaerobic, Gram-positive, and spore-forming bacterium

  • The clinical manifestations are determined by several major factors, including the strain type and associated virulence [3], the host immune response [4], disruptions in the host’s microbiome [5], patient medications [6], and gastric acid suppression [7]

  • The MyCode® Community Health Initiative (MyCode) is an ongoing project with deidentified electronic health record (EHR) linked to genomic data supporting genetic studies [21,22,23]

Read more

Summary

Introduction

Clostridioides difficile (C. difficile) is an anaerobic, Gram-positive, and spore-forming bacterium. C. difficile is a major cause of antibiotic-associated diarrhea. It is associated with the community-acquisition of diarrhea. A surveillance study across 10 geographic areas in the United States in 2011 estimated 453,000 incident C. difficile infections (CDI) and 29,000 associated deaths per year [1]. Individuals who harbor C. difficile in their gut may be carriers with no discernible symptoms, may have diarrhea of variable severity, or may progress from fulminant colitis to systemic disease and death [2]. Clostridioides difficile is a major cause of healthcare-associated and community-acquired diarrhea. Host genetic susceptibility to Clostridioides difficile infection has not been studied on a large-scale

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call